1247 (1247) Fair Value & Analysis

Consumer Cyclical · Market cap HK$247M

1 1247 1247 · HK

PriceHK$1.11

Fair ValueHK$0.2000

Upside-82.0%

Quality35/100

Evidence: Low Range HK$0.1300 – HK$0.2500

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −8.3% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$1.09 – HK$3.35 · fair‑value band HK$0.1300 – HK$0.2500 · the HK$1.11 price screens above the HK$0.2000 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1247 (1247) currently trades at HK$1.11, while our model-based Fair Value estimate is HK$0.2000 — implying the stock looks roughly 82.0% overvalued today. We read business quality at 35/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1247 generated revenue of HK$608M at a net margin of -9.7%. Revenue grew 11.7% year over year. It earns a return on equity of -47.6%. The balance sheet holds a net cash position of HK$45.2M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$608M

Revenue growth (YoY) +11.7%

Net margin -9.7%

Return on equity -47.6%

Free cash flow −HK$22.4M FY2025

Operating margin -17.4%

More key figures

EPS (TTM) HK$-0.0200

Net cash HK$45.2M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1247 reported revenue of HK$608M in FY2025 versus HK$137M in FY2021, a compound +45.3%/yr. Reported net income was −HK$59.0M in FY2025.

Revenue +45.3%/yr

FY21 HK$137M

FY22 HK$142M

FY23 HK$151M

FY24 HK$389M

FY25 HK$608M

Net income

FY21 −HK$25.0M

FY22 −HK$10.3M

FY23 −HK$12.7M

FY24 −HK$28.4M

FY25 −HK$59.0M

Is 1247 fairly valued? → Check now

Similar stocks

6 more Apparel Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
H & M Hennes & Mauritz AB HMB	kr 164.90	kr 165.47	+0%
Ralph Lauren Corporation RL	$376.43	$423.69	+13%
Moncler S.p.A MONC	€50.90	€50.69	-0%
Gildan Activewear Inc GIL	$57.04	$34.84	-39%
LPP SA LPP	21,720 PLN	18,670 PLN	-14%
Levi Strauss & Co LEVI	$23.61	$16.83	-29%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1247 (1247) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.2000 versus a price of HK$1.11 — about −82% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1247?

Our model-based fair value for 1247 is HK$0.2000 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.11.

What is the quality score of 1247?

1247 has a Quality Score of 35/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1247 (1247)?

1247 reported trailing-twelve-month revenue of about HK$608M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1247?

The net profit margin of 1247 is about -9.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.